全文获取类型
收费全文 | 490087篇 |
免费 | 61089篇 |
国内免费 | 26795篇 |
专业分类
耳鼻咽喉 | 8302篇 |
儿科学 | 8923篇 |
妇产科学 | 7424篇 |
基础医学 | 44395篇 |
口腔科学 | 7295篇 |
临床医学 | 73425篇 |
内科学 | 97759篇 |
皮肤病学 | 10548篇 |
神经病学 | 33459篇 |
特种医学 | 18768篇 |
外国民族医学 | 214篇 |
外科学 | 74740篇 |
综合类 | 55228篇 |
现状与发展 | 151篇 |
一般理论 | 21篇 |
预防医学 | 28464篇 |
眼科学 | 13089篇 |
药学 | 36100篇 |
359篇 | |
中国医学 | 19168篇 |
肿瘤学 | 40139篇 |
出版年
2024年 | 1746篇 |
2023年 | 9647篇 |
2022年 | 14854篇 |
2021年 | 20219篇 |
2020年 | 18509篇 |
2019年 | 13381篇 |
2018年 | 18964篇 |
2017年 | 17594篇 |
2016年 | 17903篇 |
2015年 | 23258篇 |
2014年 | 33906篇 |
2013年 | 31701篇 |
2012年 | 29671篇 |
2011年 | 32676篇 |
2010年 | 27361篇 |
2009年 | 27209篇 |
2008年 | 23797篇 |
2007年 | 22080篇 |
2006年 | 24394篇 |
2005年 | 21334篇 |
2004年 | 14338篇 |
2003年 | 12519篇 |
2002年 | 11324篇 |
2001年 | 11947篇 |
2000年 | 11682篇 |
1999年 | 12541篇 |
1998年 | 9252篇 |
1997年 | 9099篇 |
1996年 | 7809篇 |
1995年 | 7236篇 |
1994年 | 5251篇 |
1993年 | 3701篇 |
1992年 | 4252篇 |
1991年 | 3869篇 |
1990年 | 3198篇 |
1989年 | 3053篇 |
1988年 | 2597篇 |
1987年 | 2220篇 |
1986年 | 2012篇 |
1985年 | 1637篇 |
1984年 | 1073篇 |
1983年 | 894篇 |
1982年 | 758篇 |
1981年 | 638篇 |
1980年 | 547篇 |
1979年 | 529篇 |
1978年 | 410篇 |
1977年 | 485篇 |
1975年 | 344篇 |
1972年 | 381篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
81.
82.
83.
Prostatitis and male infertility are frequent disorders, and the role of prostatitis in male infertility has been under discussion for more than 30 years. Many researchers have shown relevant links between the two. Although a causal relationship has not been definitely demonstrated, increasing evidence shows that chronic prostatitis has a relevant negative impact on male fertility potential, at least in certain subgroups. In the following review, we focus on the present state of knowledge on the role of chronic prostatitis as an etiologic factor in male infertility. 相似文献
84.
J. Curtis Nickel MD 《Current Prostate Reports》2006,4(3):132-137
Medical therapy is currently the most popular treatment choice for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Because medical therapy of BPH-related LUTS is considered a life-long strategy, short- and long-term cost considerations should play a major role in therapeutic decision-making. The effectiveness in terms of long and short amelioration of symptoms, flow rate, and quality of life are well documented for 5α-blockers and 5α-reductase inhibitors as well as for the gold standard treatment for BPH, transurethral resection of the prostate and minimally invasive therapies. Short-and long-term safety concerns also are well documented for these various treatment options. On the contrary, short- and long-term costs have been less well studied and comparisons depend on the model or analyses undertaken in the few studies available. However, the economic studies based on prospective clinical trial data that have become available throughout the past several decades allow us to rationalize our use of α-blockers, 5α -reductase inhibitors, and combination therapy, taking into consideration age, severity of symptoms, prostate volume, prostate-specific antigen, and the differential response of the various medications (and combination) in selected patients. Based on current studies, 5α -blockers generally provide cost-effective therapy for most patients, whereas 5α-reductase therapy and combination therapy provide cost-effective treatment for patients with larger prostate glands or higher baseline prostate-specific antigen levels. 相似文献
85.
86.
INTRODUCTION: The clinical presentation of morphea varies from localized plaques to generalized eruptions. Its cause remains unknown and medical treatments have often proved unsatisfactory. Studies have previously shown that improvement of hypertrophic scars and fibrotic skin can be achieved with the use of a 585 nm pulsed dye laser (PDL). METHODS: A case of plaque-type morphea was treated with 585 nm pulsed dye laser irradiation at an average fluence of 5.0 J/cm2 at bimonthly time intervals. RESULTS: Marked clinical improvement as evidenced by improved pliability and skin coloration was seen after 4 successive PDL treatments. No side effects or complications were encountered. CONCLUSION: Pulsed dye laser therapy is a viable treatment option for morphea. The mechanism of its effect in this condition remains unknown. 相似文献
87.
杨娅 Thomas Bartel Loredana Latina Guido Caspari 王新房 Raimund Erbel 《华中科技大学学报(医学英德文版)》2002,22(2):158-163
Coronary flow reserve (CFR) has been used toassess coronary microcirculation and epicardial coro-nary stenoses[1— 3 ] . CFR is defined as the ratio ofcoronary flow under maximal coronary vasodilatationto coronary flow under resting conditions[4 ] .Whenthe cross- sectional area of epicardial coronary arteriesis constant,coronary flow velocity (CFV) ratios areequal to volume flow ratios.The most common method used clinically formeasuring CFVR is intracoronary Doppler flow(ICD) analysis re… 相似文献
88.
目的:观察离体心脏左心室三层心肌的单相动作电位的改变,以探讨扩张型心肌病易发心室颤动与三层心肌跨室壁复极不均一性的关系。方法:用阿霉素制作扩张型心肌病家兔模型,测定其室颤阈值(VFT)以及心外膜、中层心肌和心内膜心肌细胞的单相动作电位复极90%时程(APD90)、跨室壁复极离散度(TDR)。结果:扩张型心肌病VFT明显降低(P<0.001),三层心肌细胞APD90均明显延长(P<0.001),中层心肌细胞较心外膜、心内膜下心肌细胞延长更为显著(P<0.05);扩张型心肌病跨室壁复极离散度增加(P<0.01)。结论:中层心肌细胞APD90明显延长、跨室壁复极离散度增加、三层心肌复极不均一性增加可能是扩张型心肌病容易发生心室颤动的重要原因。 相似文献
89.
Angiotensin Converting Enzyme Inhibitors: Animal Experiments Suggest a New Pharmacological Treatment for Alcohol Abuse in Humans 总被引:1,自引:0,他引:1
G. Spinosa MSc E. Perlanski Dipl Tech. F. H. H. Leenen MD R. B. Stewart MSc L. A. Grupp DSc 《Alcoholism, clinical and experimental research》1988,12(1):65-70
The prevalence of heavy alcohol consumption is a major problem of increasing proportions throughout the world. Although alcohol sensitizing drugs and more recently serotonin uptake inhibitors are drug interventions with some following, their long term beneficial consequences have yet to be demonstrated. In recent years, we have demonstrated that manipulating activity in the renin-angiotensin system will dramatically alter voluntary alcohol consumption in rats. Based on these findings, the present study evaluated the ability of a class of drugs known as the angiotensin converting enzyme inhibitors to reduce voluntary alcohol drinking in laboratory animals. These drugs prevent the conversion of angiotensin I to angiotensin II. They have been licensed for use in Europe and North America and are indicated in the treatment of hypertension. Our experiments showed that both captopril (Capoten, Squibb) and enalapril (Vasotec, Merck Sharpe & Dohme) can reduce alcohol drinking in both normotensive and hypertensive animals regardless of whether the pattern of intake is in a bout or of a less exaggerated nature. Furthermore, this change in alcohol intake can occur without concomitant changes in blood pressure, plasma renin activity, overall fluid balance, or the distribution and metabolism of alcohol. Taken together these findings suggest that the angiotensin converting enzyme inhibitors should be evaluated in a clinical setting for they may prove to be a useful new treatment or treatment adjunct for alcohol abuse in humans. 相似文献
90.